Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Mol Biol (Noisy-le-grand) ; 67(1): 165-170, 2021 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-34817351

RESUMEN

In current study, Maize (Zea mays L.) husk leave extracts were appraised for biological activities such as cytotoxicity, antidiabetic, antioxidant and antimicrobial. Maceration was performed to collect various fractions of husk leave extracts using a pool of solvents i.e., n-hexane, chloroform, ethyl acetate, butanol and methanol. Antioxidant potential was measured by 1,1-diphenyl-2-picrylhydrazyl (DPPH) scavenging, reducing power and linoleic acid oxidation assay, using butylated hydroxy toluene (BHT) as a positive control. Total phenolic and flavonoid contents were found to be 18.47-425.11 mg/100 g GAE and 5.83-16.72 mg/100 g CE, respectively. The DPPH scavenging assay was exhibited in the range of 76.36 to 88.53%. The percentage inhibition in linoleic acid oxidation was found from 10.16 to 79.51%. Significant antimicrobial activity was demonstrated by husk leaf extracts against bacterial strains and fungal strains using disc diffusion and minimum inhibitory concentration (MIC) method. Amylase alpha assay was employed to analyze the antidiabetic activity which ranged between 9.52-24.81%. Cytotoxicity was evaluated by % age lysis (0.35-9.54%), while thrombolytic activity ranged between 7.67 to 31.27%. The results presented in this study revealed that maize (Zea mays L.) husk leaf extracts can be a valuable source of biologically active compounds and may be consumed as a source of potent herbal medicine in pharmaceuticals.


Asunto(s)
Antioxidantes/farmacología , Hipoglucemiantes/farmacología , Hojas de la Planta/química , Zea mays/química , Antiinfecciosos/química , Antiinfecciosos/farmacología , Antioxidantes/química , Aspergillus niger/efectos de los fármacos , Aspergillus niger/fisiología , Bacillus subtilis/efectos de los fármacos , Bacillus subtilis/fisiología , Supervivencia Celular/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Eritrocitos/citología , Eritrocitos/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Escherichia coli/fisiología , Hemólisis/efectos de los fármacos , Humanos , Hipoglucemiantes/química , Pruebas de Sensibilidad Microbiana/métodos , Extractos Vegetales/química , Extractos Vegetales/farmacología
2.
Cell Mol Biol (Noisy-le-grand) ; 67(1): 147-152, 2021 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-34817354

RESUMEN

ancer is the leading cause of death, accounting for approximately one out of six people dying with this disease worldwide. Among all, the breast and ovarian cancers are top-ranked causes of women mortalities compared to other disorders. Although, there is advancement in technologies, but still, there are unresolved concerns to overcome the global disease burden. Currently, plants are being explored as a natural remedy to cure disorders. This research was planned to explore phytochemicals in methanolic extracts of Zizyphus mauritiana and Triticum aestivum, and their pharmacological activities were studied through Agrobacterium tumefaciens bacteria, in vitro breast cancer cell line and ovarian cancer cell line to find out novel candidates in disease control and prevention. Eleven different types of bioactive compounds were analysed in the tested extracts. The highest crude extracts percentage (75±0.02) was observed with Z. mauritiana. The extracts showed promising cell growth inhibition and tumor initiation inhibition in potato disc assay. MTT assay and Incucytes imaging analysis revealed that Z. mauritiana extract had a higher anticancer potential with 40 ± 0.92 cell viability against breast cancer cells (SKBR3) and 45 ±0.29 against ovarian cancer cells (SKOV3). In conclusion, these extracts could be used as chemotherapeutics owing to their cheapness, and easy availability. While detailed study is required for further purification and characterization of bioactives/target compounds and in-vivo activity confirmations.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Neoplasias de la Mama/patología , Neoplasias Ováricas/patología , Fitoquímicos/farmacología , Extractos Vegetales/farmacología , Alcaloides/análisis , Alcaloides/farmacología , Antineoplásicos Fitogénicos/análisis , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Femenino , Flavonoides/análisis , Flavonoides/farmacología , Humanos , Fenoles/análisis , Fenoles/farmacología , Fitoquímicos/análisis , Extractos Vegetales/análisis , Taninos/análisis , Taninos/farmacología , Triticum/química , Ziziphus/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA